Cargando…

Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation

BACKGROUND: Digital therapeutic platforms facilitate health care through patient-centered strategies based on multidisciplinary teams and shared decision-making. Such platforms can be used for developing a dynamic model of diabetes care delivery, which can help in improving glycemic control by promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Shilpa, Verma, Ritika, Lathia, Tejal, Selvan, Chitra, Tanna, Snehal, Saraf, Amit, Tiwaskar, Mangesh, Modi, Alok, Kalra, Sanjay, K, Vasudevarao, Chitale, Manoj, Malde, Forum, Abdul Khader, Mohammed, Singal, Arbinder Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193208/ https://www.ncbi.nlm.nih.gov/pubmed/37133922 http://dx.doi.org/10.2196/43292

Ejemplares similares

What’s in a Name? Redefining Type 2 Diabetes Remission
por: Kalra, Sanjay, et al.
Publicado: (2021)

Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
por: Singal, Arbinder, et al.
Publicado: (2022)

Abstract 136: Video-based supervised exercise intervention successfully improves fitness in people with Type 2 diabetes: Outcomes from Diabefly(®) digital therapeutics platform
por: Singal, Arbinder, et al.
Publicado: (2022)

Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days
por: Verma, Ritika, et al.
Publicado: (2022)

Abstract 140: Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on diabefly(®) digital therapeutics program using multidisciplinary approach
por: Singal, Chitra Selvan Arbinder, et al.
Publicado: (2022)

The Weight of Words: Indian Physicians’ Perspectives on Patient Communication to Promote Diabetes Adherence
por: Selvan, Chitra, et al.
Publicado: (2021)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

Abstract 44: Persons living with diabetes in India – Their experiences and expectations from the physician
por: Selvan, Chitra, et al.
Publicado: (2022)

Digital Therapeutics in Diabetes: A Significant Tool to Address Employees’ Health and Productivity
por: Singal, Arbinder Kumar, et al.
Publicado: (2022)

The Weight of Words: A Mixed Methods Study to Understand Indian Doctors’ Perspectives and Experiences of Patient Communication
por: Selvan, Chitra, et al.
Publicado: (2021)

Response from Authors to Letter to Editor ‘In Search of Unity in Diversity’
por: Selvan, Chitra, et al.
Publicado: (2022)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
por: Ni, Kevin, et al.
Publicado: (2023)

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes
por: Bergenstal, Richard M, et al.
Publicado: (2021)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective
por: Viswanathan, Vijay, et al.
Publicado: (2019)

SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
por: Mazori, Alon Y, et al.
Publicado: (2023)

Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach
por: Kalra, Sanjay, et al.
Publicado: (2022)

Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
por: Karakuş, Kağan Ege, et al.
Publicado: (2021)

PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)

Quantifying Remission Probability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2021)

Improving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India
por: Hebbar, Meghnaa, et al.
Publicado: (2023)

Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
por: Ghosh, Sujoy, et al.
Publicado: (2020)

Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes
por: Poolsup, Nalinee, et al.
Publicado: (2013)

A systematic bibliometric analysis on the clinical practice of CGM in diabetes mellitus from 2012 to 2022
por: Kong, Laixi, et al.
Publicado: (2023)

Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications
por: Manfredo, Jacquelyn, et al.
Publicado: (2023)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors
por: Mathias, Priyanka, et al.
Publicado: (2022)

IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India
por: Verma, R., et al.
Publicado: (2022)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy
por: Crow, Hanna, et al.
Publicado: (2022)

Relationship between CGM-derived nocturnal hypoglycemia and subjective sleep quality in people with type 1 diabetes
por: Gardner, Daphne, et al.
Publicado: (2023)

Fibro-calculous pancreatic diabetes: Changing hues with changing times
por: Selvan, Chitra, et al.
Publicado: (2012)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Thromboprophylaxis for improving outcomes in COVID-19: An Indian expert consensus through virtual participation by 810 physicians
por: Vora, Agam, et al.
Publicado: (2020)

THROMBOPROPHYLAXIS FOR IMPROVING OUTCOMES IN COVID-19: AN INDIAN EXPERT CONSENSUS THROUGH VIRTUAL PARTICIPATION BY 810 PHYSICIANS
por: Vora, Agam, et al.
Publicado: (2021)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes
por: Capaldo, Brunella, et al.
Publicado: (2020)

Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
por: Hochfellner, Daniel A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lk0dt1ibbaiuhutp7t6qc4fji3